Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/655502


Delivering Drugs by Inhalation - Emerging Therapeutic Opportunities


Description: Advances in drug formulation and inhalation device design are creating new opportunities for inhaled drug delivery as an alternative to oral and parenteral delivery methods. Much of the interest in pulmonary delivery of systemic drug therapies is focused on chronic diseases and refractory conditions – aliments that require frequent drug administration for a protracted period of time. The role of device design and development in defining and driving emerging opportunities in this sector cannot be overstated. Nebulizers, metered dose inhalers (MDIs), and dry powder inhalers (DPIs) have each found a niche in the quest for optimal treatment and convenient use. While nebulizers have evolved relatively independently of the drug formulations they deliver, the current generation of MDIs and DPIs have been developed or tailored for the specific pharmaceutical being delivered, resulting in improved performance. Several of the emerging drug products covered in this report will have a significant impact in the therapeutic markets they target, improving patient compliance and effectively changing the way important illnesses and conditions are treated.

Market Data
The study presents qualitative and quantitative data and information on key market measures and benchmarks:
-Inhaled Drug Delivery Market Segment size and AGR
-Device-Pharma Alliance Activity and Deal Structure
-Inhaled Drug Economic Factors
-Strategic Positioning Factors
-Industry Structure & Competitive Landscape
-Combination Product Design Parameters
-Third-party Stakeholders Market Participant Profiles
-Market Dynamics & Sensitivities
-Competitive Risks
-Proprietary Technology Assessment
-Self-Administration Compliance Factors
-Technology Risk Factors
-Regulatory Risk Factors

Forecasts and Projections cover the Period 2008-2011

Methodology:

Research methodology is based on primary research in the form of in-depth interviews with key market participants, technology developers, distributors, industry experts, and market influencers, a list that includes regulatory officials, industry trade groups, and materials standards organizations.

Primary data is evaluated and normalized against secondary sources including trade journal articles, technical literature, industry publications, company data sheets and published information, and statistical data from government agencies and trade associations.

Forecasts and projections of market demand and future market activity are derived using standard modeling and statistical techniques


Contents: Executive Summary

Inhaled Drug Delivery Market Dynamics
- Portrait of an Evolving Market
- Established Therapeutic Targets
- Emerging Therapies
- Demographics and Growth
- Competing Technologies
- Market Drivers
- Factors Limiting Growth

Inhalation Technology
- Drug Formulations
- Inhaler Designs
- Dry Powder Inhalers
- Metered Dose Inhalers
- Nebulizers
- Performance Factors
- Bioavailability
- Dose Reproducibility
- Active Compound Stability
- Commercial Devices
- Development-Stage Devices
- Combination Products
- Emerging Device Technologies

Inhaled Drugs – Development-stage Product Candidates
- Anaphylaxis
- Cardiovascular Medicine
- Hereditary Diseases
- Immunology
- Infectious Diseases
- Metabolic
- Growth Deficiencies
- Osteoporosis
- Neurology
- Antipsychotics
- Migraine
- Parkinson’s
- Oncology
- Pain Management
- Respiratory
- Sexual Health

Market Factors
- Device Packaging
- Regulatory Issues
- Patient Compliance
- The Role of CMOs/CSOs
- Healthcare Economics

Company Profiles
- Detailed Profiles of Market Sector Participants


Companies Mentioned -3M -Akela Pharma -Alexza -Alkermes -AstraZeneca -Boehringer Ingelheim -Chiesi Farmaceutici -Direct Haler A/S -GlaxoSmithKline -Hovione -MAP Pharmaceuticals -MannKind Corporation -Meda -Microdose Technologies -Nektar Therapeutics -Novartis -Omron -Oriel Therapeutics -PARI Pharma -Respirics -Sepracor -Teva -Vectura -Viatris -YM Bioscience


Ordering: Order Online - visit http://www.researchandmarkets.com/reports/655502

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 27/11/2009 22:34:00
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net

Order information
Please verify that the product information is correct and select the format you require.
Product Name:
Delivering Drugs by Inhalation - Emerging Therapeutic Opportunities
Web Address:
http://www.researchandmarkets.com/reports/655502
Office Code:
OC8HJNPOUMUXU

Report formats
Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Single User €1,914.00
CD ROM €1,914.00 + EUR€ 50.00 Shipping/Handling *
Hard Copy €1,914.00 + EUR€ 50.00 Shipping/Handling *
Electronic (PDF) - Site License €3,022.00
Electronic (PDF) - Enterprisewide €4,365.00
* Shipping/Handling is only charged once per order.


Contact information
Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
Research and Markets Page 2 of 2
Printed 27/11/2009 22:34:00

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder's Name:
Cardholder's Signature:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)